Clinical Trial Update: A Study of Ixazomib Plus Lenalidomide and Dexamethasone in Adult Japanese Participants With Relapsed and/or Refractory Multiple Myeloma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating ixazomib plus lenalidomide and dexamethasone in adult Japanese patients with relapsed/refractory multiple myeloma has completed with re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• And or Refractory Multiple Myeloma

Drugs mentioned

• DEXAMETHASONE (Dexamethasone)
• Lenalidomide (lenalidomide)
• ixazomib (ixazomib)

Snippet

Sponsor: Takeda | Conditions: Relapsed and/or Refractory Multiple Myeloma | Phase 2 | Status: COMPLETED | Results posted: 2020-09-18